Ivana Magovcevic-Liebisch
Chief Executive Officer at VIGIL NEUROSCIENCE, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Ivana Magovcevic-Liebisch is currently the President, Chief Executive Officer & Director at Vigil Neuroscience, Inc. and a Director at Acrivon Therapeutics, Inc. She is also an Advisor at Atlas Venture Advisors, Inc. and a Trustee at Suffolk University, Museum of Science, and The Boston Ballet, Inc. Her former positions include Chairman at Absci Corp., Senior VP & Head-Global Business Development at Teva Pharmaceutical Industries Ltd., and Chief Operating Officer & Executive Vice President at Dyax Corp.
She also served as an Independent Director at Spyre Therapeutics, Inc. and Beacon Therapeutics (USA), Inc. Dr. Magovcevic-Liebisch holds an undergraduate degree from Wheaton College (Illinois), a doctorate from Harvard Medical School, and a graduate degree from Suffolk University Law School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ABSCI CORPORATION
0.16% | 2023-03-30 | 179,328 ( 0.16% ) | 1 M $ | 2024-03-30 |
VIGIL NEUROSCIENCE, INC.
0.56% | 2024-02-29 | 207,687 ( 0.56% ) | 708 213 $ | 2024-03-30 |
2024-02-07 | 0 ( -.--% ) | - $ | 2024-03-30 |
Ivana Magovcevic-Liebisch active positions
Companies | Position | Start |
---|---|---|
VIGIL NEUROSCIENCE, INC. | Chief Executive Officer | 2020-06-30 |
ACRIVON THERAPEUTICS, INC. | Director/Board Member | 2024-02-07 |
Suffolk University | Director/Board Member | - |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - |
The Boston Ballet, Inc.
The Boston Ballet, Inc. Media ConglomeratesConsumer Services The Boston Ballet, Inc. is non for profit company engages in classical professional ballet. The company was founded by E. Virginia Williams in 1979 and is headquartered in San Diego, CA. | Director/Board Member | - |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA. | Director/Board Member | - |
Former positions of Ivana Magovcevic-Liebisch
Companies | Position | End |
---|---|---|
SPYRE THERAPEUTICS, INC. | Director/Board Member | 2023-11-21 |
ABSCI CORPORATION | Chairman | 2023-06-13 |
APPLIED GENETIC TECHNOLOGIES CORPORATION | Director/Board Member | 2022-03-08 |
░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Ivana Magovcevic-Liebisch
Wheaton College (Illinois) | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Suffolk University Law School | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 7 |
---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
IPSEN | Health Technology |
SPYRE THERAPEUTICS, INC. | Health Technology |
AXCA HEALPAR | Health Technology |
ABSCI CORPORATION | Health Technology |
ACRIVON THERAPEUTICS, INC. | Health Technology |
VIGIL NEUROSCIENCE, INC. | Health Technology |
Private companies | 7 |
---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
Dyax Corp.
Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Beacon Therapeutics (USA), Inc.
Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA. | Consumer Services |
The Boston Ballet, Inc.
The Boston Ballet, Inc. Media ConglomeratesConsumer Services The Boston Ballet, Inc. is non for profit company engages in classical professional ballet. The company was founded by E. Virginia Williams in 1979 and is headquartered in San Diego, CA. | Consumer Services |
Alivio Therapeutics, Inc.
Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Ivana Magovcevic-Liebisch